The Scrubbed In Show by Peerr
The Scrubbed In Show by Peerr
Dr A.Rahyead and Dr A.Choudhury
E163: The Career pivot of a Surgeon into Pharma: Galderma, Novartis and Amicus - Dr Adaugo Onyeador (Senior Regional Medical Advisor - Amicus Therapeutics)
46 minutes Posted Nov 20, 2024 at 12:58 pm.
0:00
46:06
Download MP3
Show notes
Powered by Peerr
 
In this week’s episode Dr Adaugo shares her journey from being a surgeon to successfully transitioning into the pharmaceutical industry.  
We discussed:
🩺 Motivations to study medicine🔬 Does growing up in a science household drive curiosity?📚 Importance of having extracurricular activities while studying medicine🏥 Life as a F1/2 Doctor🔪 Inspiration to build a career in surgery👩🏽‍⚕️ Role as a clinical research fellow🧑🏽‍🔬 Discovering the role of Medical Affairs💼 Leveraging LinkedIn to build a network and learn more about the Pharma industry🌟 Securing the first role as a Medical Science Liaison at Galderma🎙️ Launching an educational podcast for GPs as a Pharma initiative🇬🇧 How do Pharma engage HCPs in the UK⚖️ MSL vs Medical Affairs roles at Pharma📈 How to CCT as a pharmaceutical physician✅ How to continue with annual appraisals and revalidation🌱 Is the grass greener on the other side?🗂️ Building a portfolio career within Pharma
Dr Adaugo (Diggi) Onyeador is a Senior Regional Medical Advisor (UK & Ireland) for Amicus Therapeutics. Prior to this she worked at Novartis and Galderma. She is medical doctor with seven years of clinical experience with a degree in pharmacology, a clinical research fellow at The Royal Free Hospital and was actively involved in TEDxEuston. 
-------------------------------------
Powered by  Peerr
 
The Health & Life Sciences Professional Network
 
We are reshaping the future of networking in the health and life sciences industry to enable a more progressive ecosystem thriving from knowledge sharing, connections and collaboration.
 
www.peerr.io
-------------------------------------
 
YouTube:Amz & Abdul
Twitter -@ScrubbedIn_Instagram - @Scrubbedin_
Follow us on Instagram & Twitter
[email protected]